The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 12

More JCP Articles

JCP
Effect of Lurasidone on Social Functioning
Original Research

January 31, 2024

Impaired social functioning in schizophrenia affects personal recovery. This analysis looked at the effects of lurasidone on social functioning in schizophrenia during a double-blind, placebo-controlled study and subsequent open-label…
JCP
Pharmacist-Led Telehealth for People With Psychosis or Bipolar Disorder
Original Research

January 29, 2024

A telehealth collaborative care program with psychiatric clinical pharmacists had strong patient participation and was associated with greater medication adherence and guideline-concordant preventive care.
, , , et al
JCP
Physical Exercise and Health, 5: Sedentary Time as a Risk Factor for Adverse Physical and Mental Health Outcomes
Clinical and Practical Psychopharmacology

January 29, 2024

Topics include why sedentariness is important, how it is defined and assessed, and why sedentary behaviors are common in daily life.
JCP
The Clinician’s Tardive Inventory
Original Research

January 24, 2024

Accurately identifying the severity and functional impact of tardive dyskinesia is essential. This report describes a new instrument, the Clinician’s Tardive Inventory, which aims to address shortcomings of existing…
, , , et al
JCP
Reckoning Risk Retrospectively: Reply to Taipale et al
Letter to the Editor

January 22, 2024

In a reply to Taipale and colleagues, Dr Andrade discusses estimation of risk in case-control studies and in RCTs.
JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
Letter to the Editor

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.
, , , et al
JCP
Suicidality Emerging From Rapid Venlafaxine Discontinuation
Case Report

January 22, 2024

This case report presents a patient with no history of suicidal crisis who experienced 2 suicidal crises within 6 months, each directly following rapid discontinuation of venlafaxine.
, , , et al
JCP
CYP2D6 Genotyping and Adverse Drug Reactions in Depression
Original Research

January 17, 2024

Genetic testing of CYP2D6 did not show that predicted poor drug metabolism led to increased adverse drug reactions in patients with depression.
, , , et al
JCP
Enriching the Assessment of Suicidal Ideation
Commentary

January 17, 2024

The processes involved in the generation of suicidal ideation (SI) can be distinguished from those involved in the acts themselves. This commentary notes that the rise of digital health…
,
JCP
Efficacy and Safety of Iloperidone in Bipolar Mania
Original Research

January 15, 2024

At 4 weeks of treatment, patients receiving iloperidone showed significant improvement on the Young Mania Rating Scale versus those receiving placebo.
, , , et al
JCP
Testing for Sleep-Disordered Breathing in Psychiatric Practice
Letter to the Editor

January 10, 2024

Dr Barry Krakow comments on Benca and colleagues’ recent review of sleep apnea in psychiatric practice and calls for clinicians to screen for sleep-disordered breathing at intake.
JCP
Clinical Outcomes of IV Ketamine for Depression
Original Research

January 8, 2024

Short-term clinical trials found intravenous (IV) ketamine to be effective in reducing depressive symptoms. This study assessed longer-term outcomes of IV ketamine for depression and explored treatment and patient…
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe